Alberti Corinne, Brun-Buisson Christian, Chevret Sylvie, Antonelli Massimo, Goodman Sergey V, Martin Claudio, Moreno Rui, Ochagavia Ana R, Palazzo Mark, Werdan Karl, Le Gall Jean Roger
Clinical Epidemiology Unit, Hôpital Robert Debré, Paris, France.
Am J Respir Crit Care Med. 2005 Mar 1;171(5):461-8. doi: 10.1164/rccm.200403-324OC. Epub 2004 Nov 5.
The systemic inflammatory response syndrome has low specificity to identify infected patients at risk of worsening to severe sepsis or shock.
To examine the incidence of and risk factors for worsening sepsis in infected patients.
A 1-year inception cohort study in 28 intensive care units of patients (n = 1,531) having a first episode of infection on admission or during the stay.
The cumulative incidence of progression to severe sepsis or shock was 20% and 24% at Days 10 and 30, respectively. Variables independently associated (hazard ratio [HR]) with worsening sepsis included: temperature higher than 38.2 degrees C (1.6), heart rate greater than 120/minute (1.3), systolic blood pressure higher than 110 mm Hg (1.5), platelets higher than 150 x 109/L (1.5), serum sodium higher than 145 mmol/L (1.5), bilirubin higher than 30 mumol/L (1.3), mechanical ventilation (1.5), and five variables characterizing infection (pneumonia [HR 1.5], peritonitis [1.5], primary bacteremia [1.8], and infection with gram-positive cocci [1.3] or aerobic gram-negative bacilli [1.4]). The 12 weighted variables were included in a score (Risk of Infection to Severe Sepsis and Shock Score, range 0-49), summarized in four classes of "low" (score 0-8) and "moderate" (8.5-16) risk (9% and 17% probability of worsening, respectively), and of "high" (16.5-24) and "very high" (score > 24) risk (31% and 55% probability, respectively).
One of four patients presenting with infection/sepsis worsen to severe sepsis or shock. A score estimating this risk, using objectively defined criteria for systemic inflammatory response syndrome, could be used by physicians to stratify patients for clinical management and to test new interventions.
全身炎症反应综合征对于识别有恶化为严重脓毒症或休克风险的感染患者特异性较低。
研究感染患者脓毒症恶化的发生率及危险因素。
在28个重症监护病房进行为期1年的起始队列研究,纳入入院时或住院期间首次发生感染的患者(n = 1531)。
在第10天和第30天,进展为严重脓毒症或休克的累积发生率分别为20%和24%。与脓毒症恶化独立相关的变量(风险比[HR])包括:体温高于38.2℃(1.6)、心率大于120次/分钟(1.3)、收缩压高于110 mmHg(1.5)、血小板高于150×10⁹/L(1.5)、血清钠高于145 mmol/L(1.5)、胆红素高于30 μmol/L(1.3)、机械通气(1.5),以及五个表征感染的变量(肺炎[HR 1.5]、腹膜炎[1.5]、原发性菌血症[1.8]、革兰氏阳性球菌感染[1.3]或需氧革兰氏阴性杆菌感染[1.4])。这12个加权变量被纳入一个评分系统(感染至严重脓毒症和休克风险评分,范围0 - 49),分为四类风险:“低”(评分0 - 8)和“中”(8.5 - 16)风险(恶化概率分别为9%和17%),以及“高”(16.5 - 24)和“极高”(评分>24)风险(概率分别为31%和55%)。
四分之一出现感染/脓毒症的患者会恶化为严重脓毒症或休克。使用客观定义的全身炎症反应综合征标准来评估这种风险的评分系统,可供医生用于对患者进行分层管理及测试新的干预措施。